Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

Conditions

• Severe Aplastic Anemia

Interventions

• DRUG: Cohort 1: hATG, CsA, EPAG Day 14 to Month 6
• DRUG: Cohort 2: hATG, CsA, EPAG Day 14 to Month 3
• DRUG: Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 6
• DRUG: Extension Cohort

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborators

• [object Object]